{ "resourceType": "Questionnaire", "id": "questionnaire-ID001", "meta": { "versionId": "1", "lastUpdated": "2025-11-11T22:30:00Z", "profile": [ "http://hl7.org/fhir/uv/rtq/StructureDefinition/rtq-questionnaire" ] }, "identifier": [ { "system": "http://hl7.org/fhir/uv/brr/identifier/qa-request", "value": "ID001", "type": { "coding": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/rtq-identifier-type", "code": "regulator-id", "display": "Regulator-issued Identifier" } ] } }, { "system": "https://ema.europa.eu/procedure-number", "value": "EMEA/H/C/005432/II/0023", "type": { "coding": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/rtq-identifier-type", "code": "regulator-id", "display": "Regulator-issued Identifier" } ] } } ], "version": "1.1.5", "name": "BRRRegulatoryQAQuestionnaire", "title": "Question Set ID001", "status": "active", "subjectType": [ "MedicinalProductDefinition" ], "date": "2025-11-11", "contact": [ { "purpose": { "coding": [ { "system": "http://hl7.org/fhir/uv/brr/CodeSystem/contact-purpose", "code": "SENDER", "display": "Sender (Health Authority)" } ] }, "organization": { "reference": "Organization/ema", "identifier": { "system": "https://ema.europa.eu/organization-id", "value": "EMA-ORG-001" }, "display": "European Medicines Agency", "name": "European Medicines Agency", "address": { "line": [ "Domenico Scarlattilaan 6" ], "city": "Amsterdam", "postalCode": "1083 HS", "country": "NL" }, "contact": [ { "telecom": [ { "system": "email", "value": "jane.doe@ema.europa.eu" }, { "system": "phone", "value": "+31-88-781-6000" } ] } ] } }, { "purpose": { "coding": [ { "system": "http://hl7.org/fhir/uv/brr/CodeSystem/contact-purpose", "code": "RECIPIENT", "display": "Recipient (Marketing Authorization Holder)" } ] }, "organization": { "reference": "Organization/synthpharma", "identifier": { "system": "urn:oid:1.3.6.1.4.1.519.1", "value": "DUNS-123456789" }, "display": "SynthPharma AG", "name": "SynthPharma AG", "address": { "line": [ "123 Synthetic Research Blvd" ], "city": "Basel", "postalCode": "4000", "country": "CH" }, "contact": [ { "telecom": [ { "system": "email", "value": "john.doe@synthpharma.example" }, { "system": "phone", "value": "+41-61-123-4567" } ] } ] } } ], "item": [ { "linkId": "admin-1", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.0", "display": "1.0 Administrative Information" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.1", "display": "1.1 Application Form" } ], "type": "question", "text": "Is the fee for the Type II variation fully paid and documented?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Is the fee for the Type II variation fully paid and documented?

See EMA Fee Guidance for payment confirmation requirements.

" } ] }, { "linkId": "admin-2", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.0", "display": "Administrative Information" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.1", "display": "Application Form" } ], "type": "group", "text": "Are all required metadata fields in the application form complete?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Are all required metadata fields in the application form complete?

" } ] }, { "linkId": "product-1", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.3", "display": "1.3 Product Information" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.3.1", "display": "SmPC, Labelling and Package Leaflet" } ], "type": "question", "text": "Do the updated storage conditions (2–8°C for 36 months) require additional patient guidance?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Do the updated storage conditions (2–8°C for 36 months) require additional patient guidance?

Current ePI states: “Store in a refrigerator (2°C – 8°C). Do not freeze.”

" } ] }, { "linkId": "product-2", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.3", "display": "Product Information" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.3.1", "display": "SmPC, Labelling and Package Leaflet" } ], "type": "question", "text": "Is the patient leaflet revised to clarify the extended shelf life?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Is the patient leaflet revised to clarify the extended shelf life?

“Shelf life after first opening: 36 months when stored at 2–8°C”

" } ] }, { "linkId": "product-3", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.3", "display": "Product Information" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "1.3.1", "display": "SmPC, Labelling and Package Leaflet" } ], "type": "question", "text": "Is the updated ePI text sufficiently clear for all EU languages?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Is the updated ePI text sufficiently clear for all EU languages?

LanguageStatus
EnglishApproved
FrenchUnder Review
GermanPending
" } ] }, { "linkId": "quality-1", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.8", "display": "Stability" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.8.1", "display": "Stability Summary and Conclusion" } ], "type": "question", "text": "Are there any new stability studies conducted, or does the submission include only data from additional timepoints from previously submitted studies?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Are there any new stability studies conducted, or does the submission include only data from additional timepoints from previously submitted studies?

" } ] }, { "linkId": "quality-2", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.8", "display": "Stability" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.8.1", "display": "Stability Summary and Conclusion" } ], "type": "question", "text": "Does the data support all intended climatic zones?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Does the data support all intended climatic zones?

Note: Confirm coverage for Zone IVb (30°C/75% RH) per WHO TRS 1010
" } ] }, { "linkId": "quality-3", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.5", "display": "Control of Drug Product" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.5.2", "display": "Analytical Procedures" } ], "type": "question", "text": "Are the test methods used the same as in the previously submitted stability information?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Are the test methods used the same as in the previously submitted stability information?

If changed: justify and provide validation data.

" } ] }, { "linkId": "quality-4", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.5", "display": "Control of Drug Product" }, { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.5.4", "display": "Impurities" } ], "type": "question", "text": "Are there any new degradation products identified within the newly submitted data?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Are there any new degradation products identified within the newly submitted data?

Threshold: >0.10% per ICH Q3B(R2)

" } ] }, { "linkId": "quality-5", "code": [ { "system": "http://hl7.org/fhir/uv/rtq/CodeSystem/ctd-categories-full", "code": "3.2.P.7", "display": "Container Closure System" } ], "type": "question", "text": "Any changes in the packaging configuration and/or storage of the samples during stability?", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/rendering-xhtml", "valueXhtml": "

Any changes in the packaging configuration and/or storage of the samples during stability?

Figure 1: Cross-section of new Alu/Alu blister showing foil thickness and sealing layer.

OriginalNew
PVC/PVDC BlisterAlu/Alu Blister
25°C/60% RHUnchanged
" } ] } ] }